Special Topics
UKAD has produced specific guidelines and resources (listed alphabetically below) for a number of common medical conditions requiring a Therapeutic Use Exemption (TUE).
Athletes who are applying for a TUE for one of the medical conditions below must complete the relevant application form and fulfil all requirements outlined in the relevant guidance documents.
Adrenaline Auto-Injectors
Athletes who are prescribed an adrenaline auto-injector for use in emergency situations (such as an allergic reaction) should refer to the following guidelines:
Adrenaline auto-injector guidelines
Asthma
Athletes requiring a TUE for a prohibited substance to treat asthma (including acute exacerbations of asthma) should refer to the following documentation:
Guidelines on acute exacerbation of asthma
Beta-2 agonist TUE application form (for specific inhalers)
Standard TUE application form (for acute exacerbations of asthma)
ADHD
Athletes requiring a TUE for stimulant medication to treat attention deficit hyperactivity disorder (ADHD) should refer to the following documentation:
Diabetes
Athletes requiring a TUE for the use of insulins to treat diabetes should refer to the following documentation:
Emergency Medications
In the course of emergency treatment (e.g. surgery or admission to A&E), athletes may be prescribed with medication or methods of administration which are prohibited in sport. Please refer to the following resource to find out when a TUE is necessary in such circumstances:
Emergency medicines infographic
Glucocorticoids
Athletes requiring a TUE for the use of a glucocorticoid should refer to the following resources to find out when a TUE is necessary and the medical evidence required to support an application:
Glucocorticoid TUE Policy FAQs
Glucocorticoid TUE Policy Infographic
Glucocorticoid pre-application checklist and TUE application form (for local injections only)
Standard TUE application form (for glucocorticoids administered by a systemic route)
Hay Fever
Athletes who are prescribed a systemic glucocorticoid (such as an intramuscular triamcinolone injection) to treat hay fever should refer to the following documentation:
Hay fever guidelines (an updated document will be shortly available in 2022)
Please note: Applications for the one-off use of an intramuscular glucocorticoid (such as triamcinolone) must be submitted in advance of commencing treatment and the injection should not be administered until a decision has been communicated by UKAD to the athlete requesting a TUE.